Agilon Health: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Agilon Health (NYSE:AGL) reported Q4 earnings with an EPS of $-0.41, missing estimates by -52.0% against an expected $-0.27. Revenue increased to $366.23 million from the previous year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 13.0% drop in share price the following day.
February 27, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agilon Health reported a significant miss in Q4 earnings with an EPS of $-0.41, underperforming against the estimate of $-0.27. Revenue saw an increase from the previous year.
Agilon Health's significant miss in EPS estimates and the historical context of share price dropping by 13.0% following last quarter's earnings miss suggest a likely negative short-term impact on AGL's stock price. The increase in revenue may not be sufficient to offset the negative sentiment generated by the earnings miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100